Multinational pharmaceutical manufacturer Pfizer announced massive profits this week on the back of large corporate tax cuts in the United States.
Pfizer will increase manufacturing in the US. Image courtesy of Flickr – Kojach In a statement to investors, Pfizer reported fourth-quarter earnings of $12.3 bn, a significant increase on the $775 million earned in the prior year. While some of this increase in income was due to additional drug sales, the…
You’ve reached your free article limit for this month. Subscribe for free to continue reading and unlock full access.
Already a subscriber? Login
